These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
318 related articles for article (PubMed ID: 30902795)
61. B-Myb Mediates Proliferation and Migration of Non-Small-Cell Lung Cancer via Suppressing IGFBP3. Fan X; Wang Y; Jiang T; Cai W; Jin Y; Niu Y; Zhu H; Bu Y Int J Mol Sci; 2018 May; 19(5):. PubMed ID: 29772705 [TBL] [Abstract][Full Text] [Related]
62. S100A2 induces metastasis in non-small cell lung cancer. Bulk E; Sargin B; Krug U; Hascher A; Jun Y; Knop M; Kerkhoff C; Gerke V; Liersch R; Mesters RM; Hotfilder M; Marra A; Koschmieder S; Dugas M; Berdel WE; Serve H; Müller-Tidow C Clin Cancer Res; 2009 Jan; 15(1):22-9. PubMed ID: 19118029 [TBL] [Abstract][Full Text] [Related]
63. Inhibition of protein phosphatase 5 suppresses non-small cell lung cancer through AMP-activated kinase activation. Hsieh FS; Hung MH; Wang CY; Chen YL; Hsiao YJ; Tsai MH; Li JR; Chen LJ; Shih CT; Chao TI; Chen KF Lung Cancer; 2017 Oct; 112():81-89. PubMed ID: 29191605 [TBL] [Abstract][Full Text] [Related]
64. MiR-183 promotes growth of non-small cell lung cancer cells through FoxO1 inhibition. Zhang L; Quan H; Wang S; Li X; Che X Tumour Biol; 2015 Sep; 36(10):8121-6. PubMed ID: 25983004 [TBL] [Abstract][Full Text] [Related]
65. Mast cells and histamine enhance the proliferation of non-small cell lung cancer cells. Stoyanov E; Uddin M; Mankuta D; Dubinett SM; Levi-Schaffer F Lung Cancer; 2012 Jan; 75(1):38-44. PubMed ID: 21733595 [TBL] [Abstract][Full Text] [Related]
66. Paired box 5 is a frequently methylated lung cancer tumour suppressor gene interfering β-catenin signalling and GADD45G expression. Zhao L; Li S; Gan L; Li C; Qiu Z; Feng Y; Li J; Li L; Li C; Peng W; Xu C; Wang Z; Hui T; Ren G; Tao Q; Xiang T J Cell Mol Med; 2016 May; 20(5):842-54. PubMed ID: 26843424 [TBL] [Abstract][Full Text] [Related]
67. TRIM47 overexpression is a poor prognostic factor and contributes to carcinogenesis in non-small cell lung carcinoma. Han Y; Tian H; Chen P; Lin Q Oncotarget; 2017 Apr; 8(14):22730-22740. PubMed ID: 28186994 [TBL] [Abstract][Full Text] [Related]
68. Disruption of BASIGIN decreases lactic acid export and sensitizes non-small cell lung cancer to biguanides independently of the LKB1 status. Granja S; Marchiq I; Le Floch R; Moura CS; Baltazar F; Pouysségur J Oncotarget; 2015 Mar; 6(9):6708-21. PubMed ID: 25894929 [TBL] [Abstract][Full Text] [Related]
69. Hepatocyte growth factor produced in lung fibroblasts enhances non-small cell lung cancer cell survival and tumor progression. Kanaji N; Yokohira M; Nakano-Narusawa Y; Watanabe N; Imaida K; Kadowaki N; Bandoh S Respir Res; 2017 Jun; 18(1):118. PubMed ID: 28619066 [TBL] [Abstract][Full Text] [Related]
70. MiR-770 inhibits tumorigenesis and EMT by targeting JMJD6 and regulating WNT/β-catenin pathway in non-small cell lung cancer. Zhang Z; Yang Y; Zhang X Life Sci; 2017 Nov; 188():163-171. PubMed ID: 28882645 [TBL] [Abstract][Full Text] [Related]
71. ETS-1 Induces Endothelial-Like Differentiation and Promotes Metastasis in Non-Small Cell Lung Cancer. Zhou X; Zhou R; Zhou H; Li Q; Hong J; Meng R; Zhu F; Zhang S; Dai X; Peng G; Wu G; Li Z Cell Physiol Biochem; 2018; 45(5):1827-1839. PubMed ID: 29510376 [TBL] [Abstract][Full Text] [Related]
72. Regulation and novel action of thymidine phosphorylase in non-small cell lung cancer: crosstalk with Nrf2 and HO-1. Tertil M; Skrzypek K; Florczyk U; Weglarczyk K; Was H; Collet G; Guichard A; Gil T; Kuzdzal J; Jozkowicz A; Kieda C; Pichon C; Dulak J PLoS One; 2014; 9(5):e97070. PubMed ID: 24819505 [TBL] [Abstract][Full Text] [Related]
73. Cucurbitacin B potently suppresses non-small-cell lung cancer growth: identification of intracellular thiols as critical targets. Kausar H; Munagala R; Bansal SS; Aqil F; Vadhanam MV; Gupta RC Cancer Lett; 2013 May; 332(1):35-45. PubMed ID: 23340170 [TBL] [Abstract][Full Text] [Related]
74. β-Apopicropodophyllin functions as a radiosensitizer targeting ER stress in non-small cell lung cancer. Kim JY; Cho JH; Kim EM; Shin HJ; Hwang SG; Song JY; Um HD; Park JK Biomed Pharmacother; 2019 May; 113():108769. PubMed ID: 30870718 [TBL] [Abstract][Full Text] [Related]
75. BRM270 inhibits cancer stem cell maintenance via microRNA regulation in chemoresistant A549 lung adenocarcinoma cells. Kwon T; Chandimali N; Huynh DL; Zhang JJ; Kim N; Bak Y; Yoon DY; Yu DY; Lee JC; Gera M; Ghosh M; Park YH; Jeong DK Cell Death Dis; 2018 Feb; 9(2):244. PubMed ID: 29445170 [TBL] [Abstract][Full Text] [Related]
76. Knockdown of toll-like receptor 4 inhibits human NSCLC cancer cell growth and inflammatory cytokine secretion in vitro and in vivo. Li D; Jin Y; Sun Y; Lei J; Liu C Int J Oncol; 2014 Aug; 45(2):813-21. PubMed ID: 24889928 [TBL] [Abstract][Full Text] [Related]
77. Apelin expression in human non-small cell lung cancer: role in angiogenesis and prognosis. Berta J; Kenessey I; Dobos J; Tovari J; Klepetko W; Jan Ankersmit H; Hegedus B; Renyi-Vamos F; Varga J; Lorincz Z; Paku S; Ostoros G; Rozsas A; Timar J; Dome B J Thorac Oncol; 2010 Aug; 5(8):1120-9. PubMed ID: 20581707 [TBL] [Abstract][Full Text] [Related]
78. Aldolase A promotes proliferation and G Fu H; Gao H; Qi X; Zhao L; Wu D; Bai Y; Li H; Liu X; Hu J; Shao S Cancer Commun (Lond); 2018 May; 38(1):18. PubMed ID: 29764507 [TBL] [Abstract][Full Text] [Related]
79. KRAS-mutation status dependent effect of zoledronic acid in human non-small cell cancer preclinical models. Kenessey I; Kói K; Horváth O; Cserepes M; Molnár D; Izsák V; Dobos J; Hegedűs B; Tóvári J; Tímár J Oncotarget; 2016 Nov; 7(48):79503-79514. PubMed ID: 27780929 [TBL] [Abstract][Full Text] [Related]
80. Nitrogen Trapping as a Therapeutic Strategy in Tumors with Mitochondrial Dysfunction. Madala HR; Helenius IT; Zhou W; Mills E; Zhang Y; Liu Y; Metelo AM; Kelley ML; Punganuru S; Kim KB; Olenchock B; Rhee E; Intlekofer AM; Iliopoulos O; Chouchani E; Yeh JJ Cancer Res; 2020 Sep; 80(17):3492-3506. PubMed ID: 32651261 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]